Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma

Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bio-Algorithms and Med-Systems de Gruyter

Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma

Loading next page...
 
/lp/de-gruyter/peptide-receptor-radionuclide-therapy-as-a-tool-for-the-treatment-of-PxTZcg5zLh
Publisher
de Gruyter
Copyright
© 2021 Walter de Gruyter GmbH, Berlin/Boston
ISSN
1896-530X
eISSN
1896-530X
DOI
10.1515/bams-2021-0138
Publisher site
See Article on Publisher Site

Abstract

Journal

Bio-Algorithms and Med-Systemsde Gruyter

Published: Jan 5, 2022

Keywords: diazoxide; hypoglycemia; insulinoma; NET; neuroendocrine tumors; PRRT

There are no references for this article.